Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1973 2
1974 2
1975 1
1985 2
1989 2
1990 1
1991 6
1992 2
1993 1
1994 9
1995 5
1996 10
1997 5
1998 5
1999 14
2000 7
2001 19
2002 17
2003 31
2004 18
2005 27
2006 27
2007 26
2008 36
2009 27
2010 28
2011 32
2012 38
2013 20
2014 15
2015 23
2016 28
2017 33
2018 24
2019 18
2020 29
2021 33
2022 15
Text availability
Article attribute
Article type
Publication date

Search Results

575 results
Results by year
Filters applied: . Clear all
Page 1
Randomized trial of TAS-102 for refractory metastatic colorectal cancer.
Mayer RJ, Van Cutsem E, Falcone A, Yoshino T, Garcia-Carbonero R, Mizunuma N, Yamazaki K, Shimada Y, Tabernero J, Komatsu Y, Sobrero A, Boucher E, Peeters M, Tran B, Lenz HJ, Zaniboni A, Hochster H, Cleary JM, Prenen H, Benedetti F, Mizuguchi H, Makris L, Ito M, Ohtsu A; RECOURSE Study Group. Mayer RJ, et al. Among authors: mizuguchi h. N Engl J Med. 2015 May 14;372(20):1909-19. doi: 10.1056/NEJMoa1414325. N Engl J Med. 2015. PMID: 25970050 Free article. Clinical Trial.
Immune Modulation by Telomerase-Specific Oncolytic Adenovirus Synergistically Enhances Antitumor Efficacy with Anti-PD1 Antibody.
Kanaya N, Kuroda S, Kakiuchi Y, Kumon K, Tsumura T, Hashimoto M, Morihiro T, Kubota T, Aoyama K, Kikuchi S, Nishizaki M, Kagawa S, Tazawa H, Mizuguchi H, Urata Y, Fujiwara T. Kanaya N, et al. Among authors: mizuguchi h. Mol Ther. 2020 Mar 4;28(3):794-804. doi: 10.1016/j.ymthe.2020.01.003. Epub 2020 Jan 10. Mol Ther. 2020. PMID: 31991110 Free PMC article.
Targeted adenovirus vectors.
Mizuguchi H, Hayakawa T. Mizuguchi H, et al. Hum Gene Ther. 2004 Nov;15(11):1034-44. doi: 10.1089/hum.2004.15.1034. Hum Gene Ther. 2004. PMID: 15610604 Review.
Monolayer platform using human biopsy-derived duodenal organoids for pharmaceutical research.
Yamashita T, Inui T, Yokota J, Kawakami K, Morinaga G, Takatani M, Hirayama D, Nomoto R, Ito K, Cui Y, Ruez S, Harada K, Kishimoto W, Nakase H, Mizuguchi H. Yamashita T, et al. Among authors: mizuguchi h. Mol Ther Methods Clin Dev. 2021 May 19;22:263-278. doi: 10.1016/j.omtm.2021.05.005. eCollection 2021 Sep 10. Mol Ther Methods Clin Dev. 2021. PMID: 34485610 Free PMC article.
The infectivity of progeny adenovirus in the presence of neutralizing antibody.
Hirai T, Sato A, Koizumi N, Kurioka Y, Suzuki Y, Kano J, Yamakawa M, Nomura T, Fujii M, Sakurai F, Mizuguchi H, Watanabe Y, Utoguchi N. Hirai T, et al. Among authors: mizuguchi h. J Gen Virol. 2021 Apr;102(4):001590. doi: 10.1099/jgv.0.001590. J Gen Virol. 2021. PMID: 33843575 Free PMC article.
Photoactivatable oncolytic adenovirus for optogenetic cancer therapy.
Hagihara Y, Sakamoto A, Tokuda T, Yamashita T, Ikemoto S, Kimura A, Haruta M, Sasagawa K, Ohta J, Takayama K, Mizuguchi H. Hagihara Y, et al. Among authors: mizuguchi h. Cell Death Dis. 2020 Jul 23;11(7):570. doi: 10.1038/s41419-020-02782-6. Cell Death Dis. 2020. PMID: 32703933 Free PMC article.
Elucidation of Inverse Agonist Activity of Bilastine.
Mizuguchi H, Wakugawa T, Sadakata H, Kamimura S, Takemoto M, Nakagawa T, Yabumoto M, Kitamura Y, Takeda N, Fukui H. Mizuguchi H, et al. Pharmaceutics. 2020 Jun 8;12(6):525. doi: 10.3390/pharmaceutics12060525. Pharmaceutics. 2020. PMID: 32521742 Free PMC article.
575 results